Yousef Baghcheghi; Farimah Beheshti; Fatemeh Seyedi; Mahdiyeh Hedayati-Moghadam; Hedyeh Askarpour; Aliasghar Kheirkhah; Ahmad Golkar; Mohammad Dalfardi; Mahmoud Hosseini

Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)

Hepatitis Monthly 18(2) (2018)

Zahra Dehnavi; Farkhonde Razmpour; Mahmoud Belghaisi Naseri; Mohsen Nematy; Seyed Ali Alamdaran; Hassan Ali Vatanparast; Mohsen Azimi Nezhad; Bita Abbasi; Azita Ganji

How Does Addition of Regular Aerobic Exercises, Influence the Efficacy of Calorie-Restricted Diet in Patients with Non-Alcoholic Steatohepatatis (NASH)?

Hepatitis Monthly 17(5) (2017)

Hossein Nikroo; Mohsen Nematy; Seyyed Reza Attarzadeh Hosseini; Hamid Reza Sima; Farkhonde Razmpour

Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran

Hepatitis Monthly 17(4) (2017)

Behnam Honarvar; Kamran Bagheri Lankarani; Parisa Keshani; Tayebe Rafiee

The Effect of Berberis Vulgaris Extract on Transaminase Activities in Non-Alcoholic Fatty Liver Disease

Hepatitis Monthly 15(2) (2015)

Raziye Iloon Kashkooli; Seyed Saeed Najafi; Farkhondeh Sharif; Azadeh Hamedi; Mohammad Kazem Hoseini Asl; Majid Najafi Kalyani; Mehdi Birjandi

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 27(5) (2021)

The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial

Middle East Journal of Digestive Diseases 14(1) (2022)

Arsia Jamali; Shahrokh Karbalai; Ghazale Tefagh; Raika Jamali; Ayat Ahmadi

Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,

Clinics and Research in Hepatology and Gastroenterology 47(1) (2023)

Cai-yan Zou; Yan Sun; Jun Liang

Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials

Obesity Reviews 25(6) (2024)

Hao Wang; Qianqian Ma; Youpeng Chen; Ling Luo; Junzhao Ye; Bihui Zhong

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Nutrition, Metabolism and Cardiovascular Diseases 32(1) (2022)

Giulio Marchesini; Elisabetta Bugianesi; Patrizia Burra; Fabio Marra; Luca Miele; Anna Alisi; Piero Vajro; Mario Masarone; Salvatore Petta; Marcello Persico; Gianluca Svegliati-Baroni; Luca Valenti; Massimo Federici; Francesco Purrello; Ferdinando Carlo Sasso; Giovanni Targher; Luca Busetto; Maria Letizia Petroni; Ferruccio Santini; Calogero Cammà; Agostino Colli

The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials

Diabetes, Obesity and Metabolism 26(5) (2024)

Rachelle Haber; Fatima Zarzour; Malak Ghezzawi; Natalie Saadeh; Dania S. Bacha; Lama Al Jebbawi; Marlene Chakhtoura; Christos S. Mantzoros

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials

Diabetes & Metabolism 46(6) (2020)

A. Mantovani; C.D. Byrne; E. Scorletti; C.S. Mantzoros; G. Targher

Effect of canagliflozin on liver function tests in patients with type 2 diabetes

Diabetes & Metabolism 42(1) (2016)

L.A. Leiter; T. Forst; D. Polidori; D.A. Balis; J. Xie; S. Sha

Pharmacological treatment and therapeutic perspectives of metabolic syndrome

Reviews in Endocrine and Metabolic Disorders 15(4) (2014)

Soo Lim; Robert H. Eckel

Relationship Between Cardiovascular Disease Risk Factors and Quality of Life in Patients with Metabolic-Associated Fatty Liver Disease

Hepatitis Monthly 22(1) (2022)

Raika Jamali; Soroush Veisi; Arsia Jamali; Mehdi Yaseri

Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition

Drug Safety 37(4) (2014)

Minjie Lin; Shuiping Zhao; Li Shen; Danyan Xu

Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic

World Journal of Gastroenterology 20(34) (2014)

Kareem Hassan

Protein analysis of rat hepatocytes under conditions glutamate-induced obesity and its correction

Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology 70(2) (2015)

D. Voieikova; L. Stepanova; O. Savchuk; L. Ostapchenko; M. Kondro

Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)

Cochrane Database of Systematic Reviews 2017(4) (2017)

Rosa Lombardi; Simona Onali; Douglas Thorburn; Brian R Davidson; Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis

Pluchea indica Leaf Extract Alleviates Dyslipidemia and Hepatic Steatosis by Modifying the Expression of Lipid Metabolism-Related Genes in Rats Fed a High Fat-High Fructose Diet

Preventive Nutrition and Food Science 27(4) (2022)

Patcharin Singdam; Jarinyaporn Naowaboot; Laddawan Senggunprai; Kampeebhorn Boonloh; Patchareewan Pannangpetch

Evaluation of PEN2-ATP6AP1 axis as an antiparasitic target for metformin based on phylogeny analysis and molecular docking

Molecular and Biochemical Parasitology 255 (2023)

Congshan Liu; Shangrui Zhang; Jian Xue; Haobing Zhang; Jianhai Yin

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy

International Journal of Molecular Sciences 22(12) (2021)

Francesca Fianchi; Antonio Liguori; Antonio Gasbarrini; Antonio Grieco; Luca Miele

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Digestive and Liver Disease 54(2) (2022)

Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map

Digestive and Liver Disease 53(1) (2021)

Jai Kumar; Roha Saeed Memon; Izza Shahid; Tehlil Rizwan; Maryam Zaman; Ritesh G. Menezes; Sarwan Kumar; Tariq Jamal Siddiqi; Muhammad Shariq Usman

Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes

Cureus (2021)

Sarunporn Kamolvisit; Supphamat Chirnaksorn; Hataikarn Nimitphong; Somnuek Sungkanuparph

Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats

Dubai Medical Journal 3(2) (2020)

Mahmoud M. Farag; Ehab H. Ashour; Wessam F. El-Hadidy

Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis

Biomedicine & Pharmacotherapy 85 (2017)

Rehab M. El-Gharabawy; Amira S. Ahmed; Amal H. Al-Najjar

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis

Acta Diabetologica 59(4) (2022)

Chen Ding; Yaxin Tang; Wenqiang Zhu; Piaopiao Huang; Pingan Lian; Juanli Ran; Xiansheng Huang

Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines

Medicine 95(5) (2016)

Raika Jamali; Abbas Arj; Mohsen Razavizade; Mohammad Hossein Aarabi

Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis

World Journal of Diabetes 12(9) (2021)

Yi-Zhou Huang; Gang-Yi Yang; Cong Wang; Xing-Yu Chen; Li-Li Zhang